Lenz Therapeutics Stock Buy Hold or Sell Recommendation
| LENZ Stock | 35.50 1.18 3.44% |
Given the investment horizon of 90 days and your highly speculative risk level, our recommendation regarding LENZ Therapeutics is 'Hold'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell LENZ Therapeutics given historical horizon and risk tolerance towards LENZ Therapeutics. When Macroaxis issues a 'buy' or 'sell' recommendation for LENZ Therapeutics, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out LENZ Therapeutics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy LENZ Stock please use our How to Invest in LENZ Therapeutics guide. In addition, we conduct extensive research on individual companies such as LENZ and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards LENZ Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
LENZ |
Execute LENZ Therapeutics Buy or Sell Advice
The LENZ recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on LENZ Therapeutics. Macroaxis does not own or have any residual interests in LENZ Therapeutics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute LENZ Therapeutics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Hold
Market Performance | Good | Details | |
Volatility | Not too volatile | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Fairly Valued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
LENZ Therapeutics Trading Alerts and Improvement Suggestions
| LENZ Therapeutics appears to be risky and price may revert if volatility continues | |
| LENZ Therapeutics was previously known as Graphite Bio and was traded on NASDAQ Exchange under the symbol GRPH. | |
| Net Loss for the year was (124.65 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| LENZ Therapeutics generates negative cash flow from operations | |
| LENZ Therapeutics has a poor financial position based on the latest SEC disclosures | |
| Over 86.0% of the company shares are owned by institutional investors | |
| Latest headline from news.google.com: Heres Why LENZ Therapeutics, Inc. Is a Great Buy the Bottom Stock Now - MSN |
LENZ Therapeutics Returns Distribution Density
The distribution of LENZ Therapeutics' historical returns is an attempt to chart the uncertainty of LENZ Therapeutics' future price movements. The chart of the probability distribution of LENZ Therapeutics daily returns describes the distribution of returns around its average expected value. We use LENZ Therapeutics price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of LENZ Therapeutics returns is essential to provide solid investment advice for LENZ Therapeutics.
| Mean Return | 0.81 | Value At Risk | -6.63 | Potential Upside | 8.04 | Standard Deviation | 4.59 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of LENZ Therapeutics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
LENZ Therapeutics Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to LENZ Therapeutics or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that LENZ Therapeutics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a LENZ stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.50 | |
β | Beta against Dow Jones | 2.55 | |
σ | Overall volatility | 4.65 | |
Ir | Information ratio | 0.15 |
LENZ Therapeutics Volatility Alert
LENZ Therapeutics shows above-average downside volatility for the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure LENZ Therapeutics' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact LENZ Therapeutics' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.LENZ Therapeutics Fundamentals Vs Peers
Comparing LENZ Therapeutics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze LENZ Therapeutics' direct or indirect competition across all of the common fundamentals between LENZ Therapeutics and the related equities. This way, we can detect undervalued stocks with similar characteristics as LENZ Therapeutics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of LENZ Therapeutics' fundamental indicators could also be used in its relative valuation, which is a method of valuing LENZ Therapeutics by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare LENZ Therapeutics to competition |
| Fundamentals | LENZ Therapeutics | Peer Average |
| Return On Equity | -1.58 | -0.31 |
| Return On Asset | -0.77 | -0.14 |
| Current Valuation | 406.07 M | 16.62 B |
| Shares Outstanding | 27.47 M | 571.82 M |
| Shares Owned By Insiders | 5.40 % | 10.09 % |
| Shares Owned By Institutions | 86.06 % | 39.21 % |
| Number Of Shares Shorted | 2.07 M | 4.71 M |
| Price To Book | 3.11 X | 9.51 X |
| EBITDA | (122.24 M) | 3.9 B |
| Net Income | (124.65 M) | 570.98 M |
| Total Debt | 362 K | 5.32 B |
| Book Value Per Share | 7.46 X | 1.93 K |
| Cash Flow From Operations | (90.01 M) | 971.22 M |
| Short Ratio | 17.72 X | 4.00 X |
| Earnings Per Share | (2.74) X | 3.12 X |
| Target Price | 33.8 | |
| Market Capitalization | 600.49 M | 19.03 B |
| Total Asset | 188.46 M | 29.47 B |
| Retained Earnings | (367.05 M) | 9.33 B |
| Annual Yield | 0.89 % | |
| Net Asset | 188.46 M |
Note: Insider Trading [view details]
LENZ Therapeutics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as LENZ . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About LENZ Therapeutics Buy or Sell Advice
When is the right time to buy or sell LENZ Therapeutics? Buying financial instruments such as LENZ Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having LENZ Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Farming Thematic Idea Now
Farming
Companies producing farming products and providing services for farmers. The Farming theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Farming Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for LENZ Stock Analysis
When running LENZ Therapeutics' price analysis, check to measure LENZ Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LENZ Therapeutics is operating at the current time. Most of LENZ Therapeutics' value examination focuses on studying past and present price action to predict the probability of LENZ Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LENZ Therapeutics' price. Additionally, you may evaluate how the addition of LENZ Therapeutics to your portfolios can decrease your overall portfolio volatility.